Saniona AB - ESG Rating & Company Profile powered by AI
Scroll down to the end of the page for potential risks for Saniona AB based on industry, geography and size. This ESG score for Saniona AB indicates the company's transparency towards the UN SDGs. The page includes a questions and answers table about Saniona AB.
Saniona AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 5.3, social score of 8.0 and governance score of 4.0.
5.8
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
521 | Smruthi Organics Ltd | 5.9 | High |
521 | Vectura Group PLC | 5.9 | High |
541 | Saniona AB | 5.8 | High |
541 | Cantargia AB | 5.8 | High |
541 | Amplia Therapeutics Ltd | 5.8 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Saniona AB have an accelerator or VC vehicle to help deliver innovation?
Does Saniona AB disclose current and historical energy intensity?
Does Saniona AB report the average age of the workforce?
Does Saniona AB reference operational or capital allocation in relation to climate change?
Does Saniona AB disclose its ethnicity pay gap?
Does Saniona AB disclose cybersecurity risks?
Does Saniona AB offer flexible work?
Does Saniona AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Saniona AB disclose the number of employees in R&D functions?
Does Saniona AB conduct supply chain audits?
Does Saniona AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Saniona AB conduct 360 degree staff reviews?
Does Saniona AB disclose the individual responsible for D&I?
Does Saniona AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Saniona AB disclose current and / or historical scope 2 emissions?
Does Saniona AB disclose water use targets?
Does Saniona AB have careers partnerships with academic institutions?
Did Saniona AB have a product recall in the last two years?
Does Saniona AB disclose incidents of discrimination?
Does Saniona AB allow for Work Councils/Collective Agreements to be formed?
Has Saniona AB issued a profit warning in the past 24 months?
Does Saniona AB disclose parental leave metrics?
Does Saniona AB disclose climate scenario or pathway analysis?
Does Saniona AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Saniona AB disclose the pay ratio of women to men?
Does Saniona AB support suppliers with sustainability related research and development?
Does Saniona AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Saniona AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Saniona AB involved in embryonic stem cell research?
Does Saniona AB disclose GHG and Air Emissions intensity?
Does Saniona AB disclose its waste policy?
Does Saniona AB report according to TCFD requirements?
Does Saniona AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Saniona AB disclose energy use targets?
Does Saniona AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Saniona AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Saniona AB
These potential risks are based on the size, segment and geographies of the company.
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which is in Phase 1 clinical stage for rare neuropathic disorders; SAN903 that is in preclinical stage for rare inflammatory, fibrotic, and hematological disorders. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.